Statement on Passage of Diagnostic and Supplemental Imaging Legislation in Massachusetts

BOSTON–(BUSINESS WIRE)–Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of H.4918, critical breast imaging legislation in Massachusetts. Diagnostic and supplemental imaging is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer. H. 4918 has been approved by the Massachusetts legislature and signed into law by